HEADER HYDROLASE INHIBITOR/HYDROLASE 19-MAY-04 1TA3 TITLE CRYSTAL STRUCTURE OF XYLANASE (GH10) IN COMPLEX WITH INHIBITOR (XIP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: XYLANASE INHIBITOR PROTEIN I; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: XIP-1; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ENDO-1,4-BETA-XYLANASE; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: GH10, 34 KDA XYLANASE, 1,4-BETA-D-XYLAN XYLANOHYDROLASE, COMPND 9 X34; COMPND 10 EC: 3.2.1.8; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRITICUM AESTIVUM; SOURCE 3 ORGANISM_COMMON: BREAD WHEAT; SOURCE 4 ORGANISM_TAXID: 4565; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: EMERICELLA NIDULANS; SOURCE 7 ORGANISM_TAXID: 162425; SOURCE 8 GENE: XLNC; SOURCE 9 EXPRESSION_SYSTEM: EMERICELLA NIDULANS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 162425 KEYWDS BETA ALPHA BARREL (XIP-I), BETA ALPHA BARREL (XYLANASE), HYDROLASE KEYWDS 2 INHIBITOR-HYDROLASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.PAYAN,P.LEONE,C.FURNISS,T.TAHIR,A.DURAND,S.PORCIERO,P.MANZANARES, AUTHOR 2 G.WILLIAMSON,H.J.GILBERT,N.JUGE,A.ROUSSEL REVDAT 5 29-JUL-20 1TA3 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 13-JUL-11 1TA3 1 VERSN REVDAT 3 24-FEB-09 1TA3 1 VERSN REVDAT 2 31-AUG-04 1TA3 1 JRNL REVDAT 1 20-JUL-04 1TA3 0 JRNL AUTH F.PAYAN,P.LEONE,S.PORCIERO,C.FURNISS,T.TAHIR,G.WILLIAMSON, JRNL AUTH 2 A.DURAND,P.MANZANARES,H.J.GILBERT,N.JUGE,A.ROUSSEL JRNL TITL THE DUAL NATURE OF THE WHEAT XYLANASE PROTEIN INHIBITOR JRNL TITL 2 XIP-I: STRUCTURAL BASIS FOR THE INHIBITION OF FAMILY 10 AND JRNL TITL 3 FAMILY 11 XYLANASES. JRNL REF J.BIOL.CHEM. V. 279 36029 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15181003 JRNL DOI 10.1074/JBC.M404225200 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 59134 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.135 REMARK 3 R VALUE (WORKING SET) : 0.133 REMARK 3 FREE R VALUE : 0.166 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2498 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4037 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1490 REMARK 3 BIN FREE R VALUE SET COUNT : 199 REMARK 3 BIN FREE R VALUE : 0.1880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4461 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 785 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.087 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.086 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.050 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.459 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4636 ; 0.014 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3934 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6295 ; 1.434 ; 1.930 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9146 ; 0.834 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 573 ; 6.115 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 665 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5246 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 975 ; 0.008 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 932 ; 0.231 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4666 ; 0.249 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2547 ; 0.084 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 534 ; 0.151 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.361 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 61 ; 0.216 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 49 ; 0.227 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2842 ; 0.727 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4529 ; 1.324 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1794 ; 2.247 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1766 ; 3.441 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1TA3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JUN-04. REMARK 100 THE DEPOSITION ID IS D_1000022501. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93400 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62367 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06100 REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.17000 REMARK 200 FOR SHELL : 4.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 8000, 0.1 M HEPES, 20% ETHYLEN REMARK 280 GLYCOL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.36500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.82700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.93600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.82700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.36500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.93600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN B -1 REMARK 465 SER B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP B 133 O HOH B 1419 1.86 REMARK 500 O HOH A 1335 O HOH A 1361 2.01 REMARK 500 O HOH A 1194 O HOH A 1371 2.09 REMARK 500 O HOH A 1332 O HOH A 1373 2.10 REMARK 500 NE2 HIS A 228 O HOH B 1419 2.14 REMARK 500 O HOH A 1220 O HOH A 1344 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2 HIS B 73 O HOH B 1419 1655 2.09 REMARK 500 OE2 GLU B 30 O HOH B 1419 1655 2.13 REMARK 500 O HOH A 1362 O HOH B 1221 3655 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 117 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ARG B 275 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 104 -136.73 -117.43 REMARK 500 PHE A 126 77.99 -113.11 REMARK 500 LEU A 127 71.38 -102.35 REMARK 500 ARG A 135 50.22 -116.34 REMARK 500 CYS A 195 86.51 -151.54 REMARK 500 LEU A 199 112.59 -164.04 REMARK 500 ASN B 44 -21.87 -142.18 REMARK 500 ASP B 161 89.16 -155.10 REMARK 500 LEU B 173 42.21 -102.74 REMARK 500 GLU B 236 45.85 -147.29 REMARK 500 VAL B 268 -72.26 -106.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TE1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FAMILY 11 XYLANASE IN COMPLEX WITH INHIBITOR REMARK 900 (XIP-I) REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS BELIEVE THAT THESE RESIDUES ARE CORRECT REMARK 999 AND GENEBANK IS INCORRECT AT THESE POSITIONS REMARK 999 (SEE PDB ENTRY 1OM0). DBREF 1TA3 A 1 274 UNP Q8L5C6 XIP1_WHEAT 31 304 DBREF 1TA3 B -1 301 UNP Q00177 XYNC_EMENI 25 327 SEQADV 1TA3 PHE A 37 UNP Q8L5C6 LEU 67 SEE REMARK 999 SEQADV 1TA3 VAL A 184 UNP Q8L5C6 ALA 214 SEE REMARK 999 SEQRES 1 A 274 ALA GLY GLY LYS THR GLY GLN VAL THR VAL PHE TRP GLY SEQRES 2 A 274 ARG ASN LYS ALA GLU GLY SER LEU ARG GLU ALA CYS ASP SEQRES 3 A 274 SER GLY MET TYR THR MET VAL THR MET SER PHE LEU ASP SEQRES 4 A 274 VAL PHE GLY ALA ASN GLY LYS TYR HIS LEU ASP LEU SER SEQRES 5 A 274 GLY HIS ASP LEU SER SER VAL GLY ALA ASP ILE LYS HIS SEQRES 6 A 274 CYS GLN SER LYS GLY VAL PRO VAL SER LEU SER ILE GLY SEQRES 7 A 274 GLY TYR GLY THR GLY TYR SER LEU PRO SER ASN ARG SER SEQRES 8 A 274 ALA LEU ASP LEU PHE ASP HIS LEU TRP ASN SER TYR PHE SEQRES 9 A 274 GLY GLY SER LYS PRO SER VAL PRO ARG PRO PHE GLY ASP SEQRES 10 A 274 ALA TRP LEU ASP GLY VAL ASP LEU PHE LEU GLU HIS GLY SEQRES 11 A 274 THR PRO ALA ASP ARG TYR ASP VAL LEU ALA LEU GLU LEU SEQRES 12 A 274 ALA LYS HIS ASN ILE ARG GLY GLY PRO GLY LYS PRO LEU SEQRES 13 A 274 HIS LEU THR ALA THR VAL ARG CYS GLY TYR PRO PRO ALA SEQRES 14 A 274 ALA HIS VAL GLY ARG ALA LEU ALA THR GLY ILE PHE GLU SEQRES 15 A 274 ARG VAL HIS VAL ARG THR TYR GLU SER ASP LYS TRP CYS SEQRES 16 A 274 ASN GLN ASN LEU GLY TRP GLU GLY SER TRP ASP LYS TRP SEQRES 17 A 274 THR ALA ALA TYR PRO ALA THR ARG PHE TYR VAL GLY LEU SEQRES 18 A 274 THR ALA ASP ASP LYS SER HIS GLN TRP VAL HIS PRO LYS SEQRES 19 A 274 ASN VAL TYR TYR GLY VAL ALA PRO VAL ALA GLN LYS LYS SEQRES 20 A 274 ASP ASN TYR GLY GLY ILE MET LEU TRP ASP ARG TYR PHE SEQRES 21 A 274 ASP LYS GLN THR ASN TYR SER SER LEU ILE LYS TYR TYR SEQRES 22 A 274 ALA SEQRES 1 B 303 GLN SER ALA SER LEU ASN ASP LEU PHE VAL ALA ALA GLY SEQRES 2 B 303 LYS SER TYR PHE GLY THR CYS SER ASP GLN ALA LEU LEU SEQRES 3 B 303 GLN ASN SER GLN ASN GLU ALA ILE VAL ALA SER GLN PHE SEQRES 4 B 303 GLY VAL ILE THR PRO GLU ASN SER MET LYS TRP ASP ALA SEQRES 5 B 303 LEU GLU PRO SER GLN GLY ASN PHE GLY TRP SER GLY ALA SEQRES 6 B 303 ASP TYR LEU VAL ASP TYR ALA THR GLN HIS ASN LYS LYS SEQRES 7 B 303 VAL ARG GLY HIS THR LEU VAL TRP HIS SER GLN LEU PRO SEQRES 8 B 303 SER TRP VAL SER SER ILE GLY ASP ALA ASN THR LEU ARG SEQRES 9 B 303 SER VAL MET THR ASN HIS ILE ASN GLU VAL VAL GLY ARG SEQRES 10 B 303 TYR LYS GLY LYS ILE MET HIS TRP ASP VAL VAL ASN GLU SEQRES 11 B 303 ILE PHE ASN GLU ASP GLY THR PHE ARG ASN SER VAL PHE SEQRES 12 B 303 TYR ASN LEU LEU GLY GLU ASP PHE VAL ARG ILE ALA PHE SEQRES 13 B 303 GLU THR ALA ARG ALA ALA ASP PRO ASP ALA LYS LEU TYR SEQRES 14 B 303 ILE ASN ASP TYR ASN LEU ASP SER ALA SER TYR ALA LYS SEQRES 15 B 303 THR GLN ALA MET ALA SER TYR VAL LYS LYS TRP LEU ALA SEQRES 16 B 303 GLU GLY VAL PRO ILE ASP GLY ILE GLY SER GLN ALA HIS SEQRES 17 B 303 TYR SER SER SER HIS TRP SER SER THR GLU ALA ALA GLY SEQRES 18 B 303 ALA LEU SER SER LEU ALA ASN THR GLY VAL SER GLU VAL SEQRES 19 B 303 ALA ILE THR GLU LEU ASP ILE ALA GLY ALA ALA SER SER SEQRES 20 B 303 ASP TYR LEU ASN LEU LEU ASN ALA CYS LEU ASN GLU GLN SEQRES 21 B 303 LYS CYS VAL GLY ILE THR VAL TRP GLY VAL SER ASP LYS SEQRES 22 B 303 ASP SER TRP ARG ALA SER ASP SER PRO LEU LEU PHE ASP SEQRES 23 B 303 GLY ASN TYR GLN PRO LYS ASP ALA TYR ASN ALA ILE VAL SEQRES 24 B 303 ASN ALA LEU SER MODRES 1TA3 ASN A 89 ASN GLYCOSYLATION SITE MODRES 1TA3 ASN A 265 ASN GLYCOSYLATION SITE HET NAG A 900 14 HET NAG A 901 14 HET EDO A1003 4 HET EDO B1001 4 HET EDO B1002 4 HET EDO B1004 4 HET EDO B1005 4 HET EDO B1006 4 HET EDO B1007 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 5 EDO 7(C2 H6 O2) FORMUL 12 HOH *785(H2 O) HELIX 1 1 ASN A 15 GLY A 19 5 5 HELIX 2 2 SER A 20 SER A 27 1 8 HELIX 3 3 ASP A 55 SER A 57 5 3 HELIX 4 4 SER A 58 LYS A 69 1 12 HELIX 5 5 SER A 88 PHE A 104 1 17 HELIX 6 6 ARG A 135 LYS A 145 1 11 HELIX 7 7 ALA A 169 ALA A 177 1 9 HELIX 8 8 GLY A 200 TYR A 212 1 13 HELIX 9 9 HIS A 232 GLY A 239 1 8 HELIX 10 10 GLY A 239 GLN A 245 1 7 HELIX 11 11 ASP A 257 ASN A 265 1 9 HELIX 12 12 ASN A 265 LYS A 271 1 7 HELIX 13 13 SER B 2 ALA B 10 1 9 HELIX 14 14 ASP B 20 ASN B 26 1 7 HELIX 15 15 ASN B 26 PHE B 37 1 12 HELIX 16 16 LYS B 47 GLU B 52 1 6 HELIX 17 17 TRP B 60 HIS B 73 1 14 HELIX 18 18 PRO B 89 SER B 94 1 6 HELIX 19 19 ASP B 97 TYR B 116 1 20 HELIX 20 20 SER B 139 GLY B 146 1 8 HELIX 21 21 GLU B 147 ASP B 161 1 15 HELIX 22 22 TYR B 178 GLU B 194 1 17 HELIX 23 23 SER B 213 THR B 215 5 3 HELIX 24 24 GLU B 216 ASN B 226 1 11 HELIX 25 25 ALA B 243 ASN B 256 1 14 HELIX 26 26 SER B 269 SER B 273 5 5 HELIX 27 27 ARG B 275 SER B 279 5 5 HELIX 28 28 LYS B 290 SER B 301 1 12 SHEET 1 A10 HIS A 48 LEU A 49 0 SHEET 2 A10 MET A 32 VAL A 40 -1 N VAL A 40 O HIS A 48 SHEET 3 A10 VAL A 73 GLY A 79 1 O SER A 76 N MET A 35 SHEET 4 A10 GLY A 122 LEU A 127 1 O ASP A 124 N ILE A 77 SHEET 5 A10 HIS A 157 VAL A 162 1 O THR A 161 N LEU A 125 SHEET 6 A10 ARG A 183 ARG A 187 1 O ARG A 187 N VAL A 162 SHEET 7 A10 ARG A 216 THR A 222 1 O GLY A 220 N VAL A 186 SHEET 8 A10 TYR A 250 TRP A 256 1 O GLY A 251 N PHE A 217 SHEET 9 A10 VAL A 8 TRP A 12 1 N THR A 9 O LEU A 255 SHEET 10 A10 MET A 32 VAL A 40 1 O THR A 34 N VAL A 10 SHEET 1 B10 HIS B 206 TYR B 207 0 SHEET 2 B10 GLU B 231 ILE B 239 1 O ASP B 238 N TYR B 207 SHEET 3 B10 CYS B 260 VAL B 265 1 O VAL B 261 N VAL B 232 SHEET 4 B10 TYR B 14 SER B 19 1 N GLY B 16 O ILE B 263 SHEET 5 B10 VAL B 39 PRO B 42 1 O VAL B 39 N THR B 17 SHEET 6 B10 LYS B 76 VAL B 83 1 O LYS B 76 N ILE B 40 SHEET 7 B10 HIS B 122 ASN B 127 1 O ASP B 124 N GLY B 79 SHEET 8 B10 LYS B 165 ASP B 170 1 O TYR B 167 N TRP B 123 SHEET 9 B10 GLY B 200 SER B 203 1 O GLY B 202 N ILE B 168 SHEET 10 B10 GLU B 231 ILE B 239 1 O ALA B 233 N SER B 203 SSBOND 1 CYS A 25 CYS A 66 1555 1555 2.05 SSBOND 2 CYS A 164 CYS A 195 1555 1555 2.13 SSBOND 3 CYS B 254 CYS B 260 1555 1555 2.32 LINK ND2 ASN A 89 C1 NAG A 901 1555 1555 1.46 LINK ND2 ASN A 265 C1 NAG A 900 1555 1555 1.78 CISPEP 1 SER A 36 PHE A 37 0 0.87 CISPEP 2 TYR A 166 PRO A 167 0 0.95 CISPEP 3 TRP A 256 ASP A 257 0 -6.39 CISPEP 4 HIS B 80 THR B 81 0 0.43 CRYST1 46.730 75.872 159.654 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021400 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006264 0.00000